← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
ScopeX — 2026 — Not specified, Boston, USA
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD). This webinar will highlight how the RCT-DUPLICATE initi
3 Presentations
3 Companies
3 Drugs
Presentation data updated Jun 12, 2026, 5:34 AM UTC
Nova Event Impact Score
60 /100
- Media coverage 20/20
- Speaker quality 14/20
- Pipeline relevance 0/20
- Historical influence 20/20
- Company participation 6/20
Key Takeaways
Key Themes
generalNot specifiedPipeline announcementsPartnership deals
Key Companies
AstraZenecaNuvalentRenovoRx
Key Drugs
durvalumab + tremelimumabneladalkibgemcitabine
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Investors & analysts
Nuvalent at ScopeX
ORAL
Pivotal data for neladalkib in TKI pre-treated patients with advanced ALK-positive NSCLC from the ALKOVE-1 study